Acute amiodarone-induced pulmonary toxicity: An association of risk factors in a child operated by arterial switch operation

Congenital Heart Disease

Volumn 3, Issue 5, 2008, Pages 365-367

  Labombarda, Fabien ^a   Ou, Phalla ^b   Stos, Bertrand ^b   de Blic, Jacques ^b   Villain, Elisabeth ^b   Sidi, Daniel ^b  

^a CAEN UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Amiodarone; Pediatric; Toxicity; Transpositionof the great arteries

Indexed keywords

AMIODARONE; PREDNISOLONE;

ARTERY SURGERY; ARTICLE; AUSCULTATION; BREATHING RATE; BRONCHITIS; CARDIOMEGALY; CASE REPORT; CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; DRUG SAFETY; DRUG WITHDRAWAL; DYSPNEA; ELECTROCARDIOGRAPHY; FIBEROPTIC BRONCHOSCOPY; GREAT VESSELS TRANSPOSITION; HUMAN; HUMAN CELL; LOADING DRUG DOSE; LUNG ALVEOLUS MACROPHAGE; LUNG FUNCTION TEST; LUNG LAVAGE; LUNG TOXICITY; MALE; NEWBORN; PLETHYSMOGRAPHY; PRIORITY JOURNAL; RESPIRATORY DISTRESS; RISK ASSESSMENT; RISK FACTOR; SUPRAVENTRICULAR TACHYCARDIA; SURGICAL TECHNIQUE; THORAX RADIOGRAPHY; TREATMENT DURATION;

ACUTE DISEASE; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; CARDIAC SURGICAL PROCEDURES; DRUG HYPERSENSITIVITY; HUMANS; INFANT; LUNG DISEASES; RISK FACTORS; TRANSPOSITION OF GREAT VESSELS;

EID: 52649178304     PISSN: 1747079X     EISSN: 17470803     Source Type: Journal    
DOI: 10.1111/j.1747-0803.2008.00208.x     Document Type: Article

References (13)

1. Vorperian VR, Havighurst TC, Miller S, January CT. Adverse effects of low dose amiodarone: A meta-analysis. J Am Coll Cardiol. 1997;30:791-798.
2. Guccione P, Paul T, Garson A. Long term follow-up of amiodarone therapy in the young: Continued efficacy, unimpaired growth, moderate side effects. J Am Coll Cardiol. 1990;15:1118-1124.
3. Bowers PN, Fields J, Schwartz D, Rosenfeld LE, Nehgme R. Amiodarone induced pulmonary fibrosis in infancy. Pacing Clin Electrophysiol. 1998;21:1665-1667.
4. Ashrafian H, Davey P. Is amiodarone an underrecognized cause of acute respiratory failure in the ICU? Chest. 2001;20:275-282.
5. Bedrossian CW, Warren CJ, Ohar J, Bhan R. Amiodarone pulmonary toxicity: cytopathology, ultrastructure, and immunohistochemistry. Ann Diagn Pathol. 1997;1:47-56.
6. Camus P, Martin WJ, Rosenow EC. Amiodarone pulmonary toxicity. Clin Chest Med. 2004;25:65-75.
7. Magro SA, Lawrence EC, Wheeler SH, Krafchek J, Lin HT, Wyndham CR. Amiodarone pulmonary toxicity: Prospective evaluation of serial pulmonary function tests. J Am Coll Cardiol. 1988;21:781-788.
8. Myers JL, Kennedy JI, Plumb VJ. Amiodarone lung: Pathologic findings in clinically toxic patients. Hum Pathol. 1987;18:349-354.
9. Coumel P, Fidelle J. Amiodarone in the treatment of cardiac arrhythmias in children: One hundred thirty-five cases. Am Heart J. 1980;100:1063-1069.
10. Villain E, Bonnet D, Iserin L, etal. Traitement et pronostic des troubles du rythme rapides après chirurgie atriale de la transposition des gros vaisseaux. Arch Mal Cæur Vaiss. 1996;89:851-856.
11. Villain E. Amiodarone as treatment for atrial tachycardias after surgery. Pacing Clin Electrophysiol. 1997;20:2130-2132.
12. Dimopoulou I, Marathias K, Daganou M, Prapas S, Stavridis G, Khoury M. Low-dose amiodarone-related complications after cardiac operations. J Thorac Cardiovasc Surg. 1997;114:31-37.
13. Rivenes SM, Grifka RG, Feltes TF. Development of advanced pulmonary vascular disease in D-transposition of the great arteries after the neonatal arterial switch operation. Tex Heart Inst J. 1998;25:201-205.